function nullOptions(aMenu){
tot=aMenu.options.length;
if (aMenu.options.length>0)
for (i=0;i<tot;i++)
{
aMenu.options[i]=null
}
aMenu.options.length=0;
}
function MySearchF(){
nullOptions(document.F187.MySelect);

URLs=new Array()
titls=new Array()
Kwds=new Array()
URLs[0]="menu1/staff.htm";
titls[0]="STAFF.HTM";
Kwds[0]="DOCTORS, STAFF, PHYSICIANS, UAB DOCTORS, NURSES";

URLs[1]="http://www.health.uab.edu/hospital/show.asp?durki=20683&site=3057&return=63303";
titls[1]="Louis B. Nabors, M.D.";
Kwds[1]="BURT NABORS MD M.D. DOCTORS";

URLs[2]="menu1/directions.htm";
titls[2]="DIRECTIONS.HTM";
Kwds[2]="DRIVING DIRECTIONS, MAP, UAB, KIRKLIN CLINIC, CCC, HOSPTIAL MAP";

URLs[3]="menu1/contact.htm";
titls[3]="CONTACT.HTM";
Kwds[3]="CONTACT, HELP, PHONE NUMBER";

URLs[4]="menu1/east.htm";
titls[4]="DIRECTIONS FROM EAST ALABAMA";
Kwds[4]="DRIVING DIRECTIONS, MAP, UAB, KIRKLIN CLINIC, CCC, HOSPTIAL MAP";

URLs[5]="menu1/how_to_help.htm";
titls[5]="HOW YOU CAN HELP.HTM";
Kwds[5]="HELP, HOW TO HELP, DONATIONS, GIFTS, GIFT, DONATE, MONEY, SHARE";

URLs[6]="menu1/north.htm";
titls[6]="DIRECTIONS FROM NORTH ALABAMA";
Kwds[6]="DRIVING DIRECTIONS, MAP, UAB, KIRKLIN CLINIC, CCC, HOSPTIAL MAP";

URLs[7]="menu1/patients_and_families.htm";
titls[7]="PATIENTS & FAMILIES.HTM";
Kwds[7]="DIRECTIONS, DRIVING, PATIENTS, FAMILIES, PATIENTS AND FAMILIES, MAP";

URLs[8]="menu1/referring_physicians.htm";
titls[8]="REFERRING PHYSICIANS.HTM";
Kwds[8]="THE BRAIN TUMOR TREATMENT AND RESEARCH PROGRAM (BTTRP) OFFERS COMMUNITY-BASED PHYSICIANS THE OPPORTUNITY TO REFER PATIENTS FOR A COMPREHENSIVE EVALUATION AND CONSIDERATION OF INVESTIGATIONAL OPTIONS. THE INVESTIGATIONAL OPTIONS INCLUDE PHASE I, II AND II HUMAN CLINICAL TRIALS FOR PATIENTS WITH PRIMARY AND METASTATIC BRAIN TUMORS. OUR CLINICAL TRIALS ARE SPONSORED BY THE NATIONAL CANCER INSTITUTE (NCI) THROUGH THE CNS CONSORTIUM NEW APPROACHES TO BRAIN TUMOR THERAPY (NABTT) AS WELL AS LARGE COOPERATIVE GROUPS SUCH AS RADIATION THERAPY ONCOLOGY GROUP (RTOG), SOUTHWEST ONCOLOGY GROUP (SWOG) OR EASTERN COOPERATIVE ONCOLOGY GROUP (ECOG) AND PHARMACEUTICAL SPONSORED TRIALS.CLINICAL TRIALS ARE OFFERED FOR VARIOUS HISTOLOGICAL TYPES AND GRADES. PROTOCOLS ARE DIVIDED INTO DIFFERENT PROTOCOL CLASSES DEPENDING ON TIME POINT IN DIAGNOSIS AND TREATMENT. TYPICAL ELIGIBILITY REQUIREMENTS ARE:GREATER THAN AGE 18 HISTOLOGICALLY CONFIRMED DIAGNOSIS MUST HAVE RECOVERED FROM TOXICITY OF PRIOR THERAPY. AN INTERVAL OF 4 WEEKS MUST HAVE ELAPSED SINCE THE COMPLETION OF STANDARD RADIATION WHILE AT LEAST 3 WEEKS MUST HAVE ELAPSED SINCE THE COMPLETION OF A NON-NITROSUREA CONTAINING CHEMOTHERAPY REGIMEN AND AT LEAST 6 WEEKS SINCE THE COMPLETION OF A NITROSUREA CONTAINING CHEMOTHERAPY REGIMEN. KARNOFSKY PERFORMANCE STATUS (KPS) OF AT LEAST 70 ABSOLUTE NEUTROPHIL COUNT ³ 1,500 CELLS/MM 3 , PLATELET COUNT > 100,000 CELLS/MM 3 , SERUM CREATININE < 2 X ULN, TRANSAMINASES £ 4 TIME THE UPPER LIMITS OF NORMAL NO PRIOR TREATMENT WITH GLIADEL, BRACHYTHERAPY, OR BIOLOGIC AGENTS PATIENTS MUST HAVE NO CONCURRENT MALIGNANCY EXCEPT CURATIVELY TREATED BASAL OR SQUAMOUS CELL CARCINOMA OF THE SKIN OR CARCINOMA IN SITU OF THE CERVIX AND BREAST. PATIENTS WITH PRIOR MALIGNANCIES MUST BEDISEASE-FREE FOR 5 YEARS. ABLE TO SIGN INFORMED CONSENT ";

URLs[9]="menu1/research_opps.htm";
titls[9]="RESEARCH OPPORTUNITIES.HTM";
Kwds[9]="RESEARCH, BRAIN TUMOR";

URLs[10]="menu1/south.htm";
titls[10]="DIRECTIONS FROM SOUTH ALABAMA";
Kwds[10]="DRIVING DIRECTIONS, MAP, UAB, KIRKLIN CLINIC, CCC, HOSPTIAL MAP";

URLs[11]="menu2/utilities.htm";
titls[11]="UTILITIES.HTM";
Kwds[11]="ASSISTANCE PROGRAMS ARE OFFERED BY MANY GAS, ELECTRIC, WATER, AND PHONE COMPANIES. IF YOU WILL HAVE DIFFICULTY PAYING YOUR MONTHLY BILLS, CONTACT THE COMPANY BEFORE YOUR BALANCE BECOMES TOO LARGE. COMPANIES ARE MORE APT TO WORK OUT A PAYMENT PLAN WITH THOSE WILLING TO WORK WITH THEM. MANY STATES HAVE REGULATIONS THAT PROHIBIT COMPANIES FROM TURNING OFF UTILITIES. YOUR DOCTOR OR SOCIAL WORKER MAY NEED TO WRITE A LETTER DESCRIBING WHY THE SERVICE(S) ARE MEDICALLY NECESSARY. THE REGULATIONS DO NOT DIMINISH YOUR RESPONSIBILITY FOR PAYING THE BILLS, BUT MAY ALLOW YOU MORE TIME TO PAY OR DECREASE THE AMOUNT PAID EACH MONTH. IN AN EMERGENCY SITUATION, CHECK WITH LOCAL HELP LINES AND SOCIAL SERVICE AGENCIES AS SOME PROVIDE ONE-TIME EMERGENCY HELP WITH UTILITY BILLS. ";

URLs[12]="menu1/western.htm";
titls[12]="DIRECTIONS FROM WESTERN ALABAMA";
Kwds[12]="DRIVING DIRECTIONS, MAP, UAB, KIRKLIN CLINIC, CCC, HOSPTIAL MAP";

URLs[13]="menu1/who_we_are.htm";
titls[13]="WHO WE ARE";
Kwds[13]="MEMBERS OF THE UAB BRAIN TUMOR TREATMENT TEAM ,THE UAB BRAIN TUMOR TREATMENT AND RESEARCH PROGRAM CONSISTS OF A MULTI-DISCIPLINARY TEAM OF EXPERTS WHO WORK TOGETHER TO CARE FOR PATIENTS WITH BRAIN TUMORS. THIS TEAM INCLUDES THE FOLLOWING HEALTH CARE PROFESSIONALS:  NEUROSURGEONS: SURGERY IS THE FIRST LINE OF TREATMENT FOR MANY BRAIN TUMORS, AND IT IS USED BOTH TO REMOVE TUMOR AS WELL AS PROVIDE TISSUE FOR ACCURATE DIAGNOSIS. THE NEUROSURGEONS WHO ARE PART OF THE BRAIN TUMOR PROGRAM TEAM ARE HIGHLY EXPERIENCED IN PERFORMING THESE PROCEDURES, AND THEY ACTIVELY COLLABORATE WITH THE OTHER MEMBERS OF THE TEAM IN THE DEVELOPMENT OF NEW, INVESTIGATIONAL TREATMENTS. RADIATION ONCOLOGISTS: RADIATION THERAPY IS THE SECOND LINE OF TREATMENT FOR MOST PATIENTS WITH BRAIN TUMORS, AND ITS USE IS COORDINATED AND SUPERVISED BY THIS GROUP OF PHYSICIANS. OUR RADIATION ONCOLOGISTS PARTICIPATE CLOSELY AS MEMBERS OF THE BRAIN TUMOR TEAM, AND PROVIDE STATE-OF-THE-ART RADIATION THERAPY FOR BRAIN TUMOR PATIENTS. FURTHERMORE, LIKE THE OTHER MEMBERS OF THE BRAIN TUMOR TEAM, THESE PHYSICIANS ARE ALSO ACTIVELY INVOLVED IN DEVELOPING NEW, EXPERIMENTAL METHODS OF ADMINISTERING RADIATION THERAPY IN ORDER TO IMPROVE THE OUTCOME FOR PATIENTS WITH BRAIN TUMORS.NEURO-ONCOLOGISTS: MEDICAL THERAPY IS THE THIRD LINE OF TREATMENT FOR PATIENTS WITH BRAIN TUMORS, AND INCLUDES CONVENTIONAL CHEMOTHERAPY AS WELL AS THE USE OF NOVEL, EXPERIMENTAL THERAPIES THAT ARE DESIGNED TO DESTROY TUMORS THAT CANNOT BE REMOVED BY SURGERY OR RADIATION THERAPY. NEURO-ONCOLOGISTS OVERSEE THIS PART OF THE TREATMENT PLAN FOR PATIENTS WITH BRAIN TUMORS. IN ADDITION, THEY TAKE CARE OF THE MEDICAL AND NEUROLOGIC PROBLEMS THAT MANY PATIENTS WITH BRAIN TUMORS DEVELOP, INCLUDING SEIZURES, INFECTIONS, AND EMOTIONAL PROBLEMS.NEUROPATHOLOGISTS: ACCURATE DIAGNOSIS OF THE TYPE OF BRAIN TUMOR THAT A PATIENT HAS IS CRITICAL, SINCE DIFFERENT TUMORS RESPOND TO DIFFERENT TYPES OF TREATMENT. AT THE UAB BRAIN TUMOR PROGRAM, OUR TEAM OF NEUROPATHOLOGISTS UTILIZE A WIDE RANGE OF CONVENTIONAL AND MOLECULAR TOOLS TO NOT ONLY DIAGNOSE BRAIN TUMORS, BUT TO PROVIDE THE TEAM WITH ADDITIONAL INFORMATION, SUCH AS WHAT TREATMENTS ARE MOST LIKELY TO BE EFFECTIVE FOR AN INDIVIDUAL BRAIN TUMOR PATIENT. THE DIVISION OF NEUROPATHOLOGY AT UAB IS ONE OF THE LARGEST IN THE COUNTRY, AND IS HIGHLY EXPERIENCED IN WORKING WITH THE REST OF THE BRAIN TUMOR TEAM. NEUROPSYCHOLOGISTS: BRAIN TUMORS CAN AFFECT PERSONALITY, MEMORY, SPEECH, AND PROBLEM-SOLVING ABILITY. NEUROPSYCHOLOGISTS MEASURE HOW THESE FEATURES CHANGE IN RESPONSE TO TREATMENT, AND IN HOW THEY IMPACT ON THE QUALITY OF LIFE. THEIR STUDIES PROVIDE OTHER MEMBERS OF THE BRAIN TUMOR TEAM WITH IMPORTANT INPUT INTO THE LONG-TERM MANAGEMENT OF PATIENTS WITH BRAIN TUMORS.NURSE PRACTITIONERS: THESE HEALTH CARE PROFESSIONALS FOLLOW THE DAY-TO-DAY PROGRESS OF THE PATIENTS SEEN IN THE PROGRAM. THEY MONITOR THE MEDICATIONS THAT OUR PATIENTS TAKE TO CONTROL THEIR MEDICAL AND NEUROLOGIC PROBLEMS, THEY FOLLOW THE EFFECTS OF CHEMOTHERAPY OR INVESTIGATIONAL THERAPY ON OUR PATIENTS' BLOOD COUNTS AND OTHER LABORATORY RESULTS, AND PAY CLOSE ATTENTION TO OUR PATIENTS' EMOTIONAL NEEDS. THEY WORK CLOSELY WITH THE PHYSICIAN MEMBERS OF THE TEAM IN FORMULATING INDIVIDUALIZED TREATMENT PLANS FOR OUR PATIENTS AND IN FOLLOWING THE RESULTS OF TREATMENT.RESEARCH SCIENTISTS: AT UAB, WE REMAIN COMMITTED TO IMPROVE HOW WE TREAT PATIENTS WITH BRAIN TUMORS. AN ESSENTIAL PART OF THIS COMMITMENT IS OUR SUPPORT OF A TEAM OF RESEARCH SCIENTISTS WHO DEVOTE THEIR EFFORTS TO IDENTIFYING PROMISING NEW TREATMENTS IN THE RESEARCH LABORATORY. THESE RESEARCH EFFORTS ARE DEVOTED TO: 1) UNDERSTANDING HOW BRAIN TUMORS START TO GROW, 2) HOW THEY SPREAD THROUGH THE BRAIN, 3) HOW THEY PROVIDE THEMSELVES WITH A BLOOD SUPPLY TO SUPPORT THEIR GROWTH, 4) HOW THEY DAMAGE NORMAL BRAIN IN THE PROCESS OF GROWING, AND 5) HOW ALL THIS INFORMATION CAN BE TRANSLATED INTO NEW THERAPIES. COOPERATION WITH OTHER BRAIN TUMOR PROGRAMS NATIONWIDE THE UAB BRAIN TUMOR PROGRAM IS A LEADING MEMBER OF ONE OF THE TWO NATIONAL BRAIN TUMOR CLINICAL COOPERATIVE GROUPS THAT ARE SUPPORTED BY THE NATIONAL CANCER INSTITUTE TO STUDY NEW, EXPERIMENTAL TREATMENTS FOR PATIENTS WITH MALIGNANT BRAIN TUMORS. OUR LEADERSHIP ROLE IN OUR CLINICAL COOPERATIVE GROUP--CALLED THE NABTT (NEW APPROACHES TO BRAIN TUMOR THERAPY) CONSORTIUM--MEANS THAT WE CAN INTRODUCE NEW FORMS OF CHEMOTHERGENE THERAPY, AND BIOLOGIC THERAPY THAT ARE ONLY AVAILABLE TO A LIMITED NUMBER OF CENTERS NATIONWIDE. FURTHERMORE, AS A MEMBER OF THE NABTT CONSORTIUM, WE COLLABORATE CLOSELY WITH THE OTHER MEMBERS (WHICH BESIDE UAB ALSO INCLUDE JOHNS HOPKINS, HARVARD, HENRY FORD HOSPITAL, THE CLEVELAND CLINIC, WAKE FOREST UNIVERSITY, THE UNIVERSITY OF PENNSYLVANIA, EMORY UNIVERSITY, AND H. LEE MOFFITT CANCER CENTER) IN SHARING CUTTING EDGE INFORMATION ON BRAIN TUMOR DIAGNOSIS AND TREATMENT. THIS PROVIDES THE UAB BRAIN TUMOR PROGRAM WITH ACCESS TO THE LATEST INFORMATION AND THE LATEST MEDICATIONS--OFTEN LONG BEFORE THESE BECOME AVAILABLE TO THE GENERAL MEDICAL COMMUNITY. THE UAB BRAIN TUMOR PROGRAM AS A CENTER OF RESEARCH EXCELLENCE OUR COMMITMENT TO IMPROVING THE OUTCOME OF PEOPLE AFFLICTED WITH BRAIN TUMORS MEANS THAT WE ARE EQUALLY COMMITTED TO FINDING NEW TREATMENTS THAT ARE MORE EFFECTIVE THAN WHAT IS CURRENTLY AVAILABLE IN THE GENERAL COMMUNITY. THIS REQUIRES A COMMITMENT TO BOTH BASIC AND APPLIED RESEARCH. FORTUNATELY, OUR BRAIN TUMOR PROGRAM'S EXCELLENCE IN CLINICAL CARE IS MATCHED BY ITS OUTSTANDING RECORD OF RESEARCH PRODUCTIVITY. WE HAVE OVER FIFTEEN LABORATORIES AT UAB THAT ARE DEVOTED TO STUDYING BRAIN TUMORS. RESEARCH WORK RUNS THE GAMUT FROM BASIC STUDIES THAT ARE ATTEMPTING TO ELUCIDATE HOW BRAIN TUMORS GROW AND INVADE TO APPLIED STUDIES THAT ARE ATTEMPTING TO CAPITALIZE ON OUR KNOWLEDGE TO DESIGN NOVEL, NON-TOXIC TREATMENTS. WHILE MUCH OF THIS RESEARCH IS SUPPORTED BY FUNDS FROM THE NATIONAL CANCER INSTITUTE, A BRANCH OF THE FEDERAL GOVERNMENT, MUCH IS ALSO SUPPORTED BY PRIVATE DONATIONS FROM THE COMMUNITY. OUR EXCELLENCE IN BASIC AND APPLIED BRAIN TUMOR RESEARCH WAS RECENTLY RECOGNIZED BY THE NATIONAL CANCER INSTITUTE, WHICH AWARDED THE UAB BRAIN TUMOR PROGRAM WITH ONE OF ONLY TWO SPECIALIZED PROGRAM IN RESEARCH EXCELLENCE (SPORE) GRANTS NATIONWIDE. THIS $11.8 MILLION GRANT IS DESIGNED TO SUPPORT FIVE RESEARCH PROJECTS AND FIVE CORE SUPPORT FACILITIES, WHICH TOGETHER ARE EXPECTED TO PRODUCE NEW TREATMENTS FOR PATIENTS WITH BRAIN TUMORS WITHIN THE NEXT FIVE YEARS. RESEARCH CONDUCTED AT UAB HAS ALREADY LED TO SEVERAL CLINICAL TRIALS IN GENE AND BIOLOGIC THERAPIES, AND WE ANTICIPATE THAT THE SPORE WILL LEAD TO AT LEAST ONE NEW BRAIN TUMOR TREATMENT OVER THE NEXT YEAR ALONE."; 

URLs[14]="menu2/food_programs.htm";
titls[14]="FOOD PROGRAMS.HTM";
Kwds[14]="MEALS ON WHEELS COORDINATES THOUSANDS OF PROGRAMS THROUGHOUT THE UNITED STATES TO DELIVER MEALS TO THOSE WHO ARE HOMEBOUND. SOME PROGRAMS REQUIRE A SMALL DONATION; EACH PROGRAM DETERMINES ELIGIBILITY. FOR A REFERRAL TO THE MEALS ON WHEELS SERVING YOUR AREA, CONTACT THE NATIONAL ELDERCARE OFFICE AT 800-677-1116. TO LOCATE ADDITIONAL FOOD PROGRAM OPTIONS, INCLUDING CONGREGATE MEAL PROGRAMS, CONTACT MEALCALL AT 704-907-6196 OR VISIT HTTP://WWW.MEALCALL.ORG/ TO SEARCH THEIR DATABASE FOR PROGRAMS IN YOUR AREA. MEALCALL OFFERS DATABASES FOR BOTH THE UNITED STATES AND CANADA. THIS INFORMATION, AS WELL AS THE SUPPORT PROGRAMS OFFERED BY ABTA, DEPENDS ON YOUR GENEROSITY. PLEASE CONSIDER MAKING A DONATION IN HONOR OF A FRIEND OR FAMILY MEMBER. A CARD WILL BE SENT NOTIFYING THEM OF YOUR THOUGHTFULNESS. YOUR DONATION WILL HELP ENSURE THE FUTURE OF THESE PROGRAMS. PLEASE CLICK HERE TO DONATE. IF YOU HAVE ANY QUESTIONS OR WOULD LIKE ADDITIONAL SUGGESTIONS, PLEASE CALL 800-886-2282 AND ASK FOR OUR SOCIAL WORK DEPARTMENT. WE WOULD ALSO APPRECIATE YOUR LETTING US KNOW OF TOPICS YOU WOULD LIKE US TO ADDRESS IN FUTURE TLC COLUMNS.";

URLs[15]="menu2/medical_care.htm";
titls[15]="MEDICAL CARE.HTM";
Kwds[15]="MEDICAL CARE, CARE, PATIENT CARE";

URLs[16]="menu2/life_insurance.htm";
titls[16]="TAPPING INTO LIFE INSURANCE.HTM";
Kwds[16]="LIFE INSURANCE, INSURANCE,LIVING BENEFITS OR ACCELERATED BENEFITS ARE PAID AS AN EARLY PAYMENT. THEIR VALUE CAN VARY BETWEEN 25-100 PERCENT OF THE TOTAL AMOUNT OF THE POLICY. THE AMOUNT AND METHOD OF PAYMENT WILL VARY WITH EACH POLICY. VIATICAL SETTLEMENTS INVOLVE THE SALE OF A LIFE INSURANCE POLICY TO A VIATICAL SETTLEMENT COMPANY. THEY, IN TURN, BECOME THE BENEFICIARY. AGAIN, EACH COMPANY WILL HAVE ITS OWN GUIDELINES. BEFORE MAKING ANY CHANGES TO A POLICY, TALK WITH SOMEONE YOU CAN TRUST, SUCH AS A FINANCIAL PLANNER, ACCOUNTANT, OR ATTORNEY. MAKE SURE YOU CLEARLY UNDERSTAND THE IMPLICATIONS BEFORE MAKING ANY FIRM DECISIONS. FOR A FREE BROCHURE VIATICAL SETTLEMENTS: A GUIDE FOR PEOPLE WITH TERMINAL ILLNESSES CALL THE FEDERAL TRADE COMMISSION AT 202-326-2222. ";

URLs[17]="menu2/tfi.htm";
titls[17]="TACKLING FINANCIAL ISSUES.HTM";
Kwds[17]="THE FINANCIAL DIFFICULTIES FACED BY BRAIN TUMOR PATIENTS AND THEIR FAMILIES ARE REAL. FEW PEOPLE KNOW ENOUGH ABOUT FINANCES AND FINANCIAL OPTIONS THAT MAY BE AVAILABLE TO THEM. ALSO, DURING AN ILLNESS OR CRISIS IT MAY BE DIFFICULT TO FIND THE TIME OR ENERGY TO RESEARCH VIABLE OPTIONS. HERE, WE TOUCH ON A FEW SOURCES OF FINANCIAL ASSISTANCE THAT MAY BE AVAILABLE TO YOU. REMEMBER YOUR FINANCIAL HEALTH IS IMPORTANT, AS IS YOUR PHYSICAL HEALTH. SEEK OUT RESOURCES; ASK FOR HELP AND FOCUS ON GETTING WELL.";

URLs[18]="menu1/brain_buddies.htm";
titls[18]="BRAIN BUDDIES.HTM";
Kwds[18]="BRAIN BUDDIES SUPPORT GROUP, THE BRAIN TUMOR CLINIC SPONSORS A BRAIN TUMOR SUPPORT GROUP CALLED BRAIN BUDDIES. THE GROUP, THE ONLY ONE OF ITS KIND IN ALABAMA , BEGAN IN APRIL 2004 WHEN BRAIN TUMOR PATIENTS AND THEIR FAMILIES EXPRESSED AN INTEREST FOR A FORMAL MEETING PLACE TO CONNECT WITH ONE ANOTHER. THE GROUP IS OPEN TO BRAIN TUMOR PATIENTS TREATED AT UAB AND ELSEWHERE.THE GROUP MEETS THE THIRD MONDAY OF EACH MONTH AND IS HELD ON THE 5 TH FLOOR OF THE KIRKLIN CLINIC IN THE NEURO-ONCOLOGY CLINIC LOCATION. THE MEETING TIME IS FROM 11:00 A.M. – 12 NOON WITH A LIGHT SNACK PROVIDED. THERE WILL BE NO MEETING IN THE MONTH OF DECEMBER.BRAIN BUDDIES PROVIDES A FORUM TO DISCUSS THE UNIQUE ISSUES THAT AFFECT BRAIN TUMOR PATIENTS, WHO OFTEN FACE SIGNIFICANT NEUROLOGICAL AS WELL AS PHYSICAL LIMITATIONS. IT ALSO PROVIDES A FORUM FOR FAMILY MEMBERS TO SPEAK WITH OTHERS FACING SIMILAR CHALLENGES. EACH SESSION INCLUDES A SHORT PRESENTATION BY A SPEAKER AND A DISCUSSION. FORMER SPEAKERS HAVE ADDRESSED TOPICS LIKE NUTRITION, MOBILITY AND MEMORY. THERE ARE INDIVIDUAL MEETINGS FOR PATIENTS AS WELL AS CAREGIVERS TO DISCUSS SPECIFIC NEEDS AND CONCERNS. CATHIE ROBINSON IS THE CO-FACILITATOR, ALONG WITH LORIE BLACK, R.N. MRS. ROBINSON'S HUSBAND, JAY, WAS 38 WHEN HE DIED FROM A BRAIN TUMOR THREE YEARS AGO. “BRAIN TUMORS AFFECT THE WHOLE FAMILY, NOT JUST THE PATIENT,” MRS. ROBINSON SAYS. “THIS GROUP IS MADE UP OF PEOPLE GOING THROUGH SIMILAR ISSUES, PATIENTS AND CAREGIVERS.”FOR MORE INFORMATION, CONTACT LORI BLACK, R.N., 205-934-1813";

URLs[19]="menu1/staff.htm";
titls[19]="STAFF.HTM";
Kwds[19]="GILLESPIE, YANCEY PHD";

URLs[20]="menu1/staff.htm";
titls[20]="James M. Markert, M.D., MPH";
Kwds[20]="JAMES MARKERT, DOCTORS";

URLs[21]="menu1/staff.htm";
titls[21]="Barton Guthrie";
Kwds[21]="BARTON GUTHRIE, DOCTORS";

URLs[22]="menu1/staff.htm";
titls[22]="Candece Gladson, M.D.";
Kwds[22]="CANDECE GLADSON, DOCTORS";

URLs[23]="menu1/staff.htm";
titls[23]="Cheryl Palmer, M.D.";
Kwds[23]="CHERYL PALMER, DOCTORS";

URLs[24]="menu1/staff.htm";
titls[24]="Steven Carroll, M.D.";
Kwds[24]="STEVEN CARROLL, DOCTORS";

URLs[25]="menu1/staff.htm";
titls[25]="John Fiveash, M.D.";
Kwds[25]="JOHN FIVEASH, DOCTORS";


function allFirstCaps(s) {
theText=s.toLowerCase();
s="";
var b=theText.split(" ");
for (var i = 0; i < b.length; i++) {
var myWord=b[i];
var firstLetter=myWord.charAt(0);
firstLetter=firstLetter.toUpperCase();
var a=myWord.length;
myWord=firstLetter+myWord.substring(1,a)+" ";
s+=myWord;
}
return s;
}//end of  allFirstCaps(s)

var joined=new Array()
{
for (i=0;i<URLs.length; i++){
joined[i]=titls[i]+Kwds[i]
}
Searchphrase=document.F187.MyText.value
j=0;
checker=0;
if (document.F187.MyText.value.length<1){
alert("Please enter something to search for.");
}
else {
var myFoundURL=new Array();
var myFoundText=new Array();
for (i=0;i<URLs.length; i++)
{
if (joined[i].indexOf(Searchphrase.toUpperCase())>-1){
checker+=1;
j++;
myFoundURL[j]=URLs[i];
myFoundText[j]=titls[i];
}
}
if (checker>0){
document.F187.MySelect.options[0]=new Option("Results: "+checker,"")
for (j=1;j<checker+1;j++)
{
document.F187.MySelect.options[j]=
   new Option(allFirstCaps(myFoundText[j]),myFoundURL[j]);
}
}
else {
document.F187.MySelect.options[0]=new Option("Sorry! Couldn\'t find anything:","")
}
}

}
//Older Netscapes like a refresh, but Microsoft doesn"t and nor does Net 7
/*if (navigator.appName.indexOf("Netscape")>-1)
history.go(0)*/
}

function searchGo(){

if (document.F187.MySelect.selectedIndex>0){
location=document.F187.MySelect.options[document.F187.MySelect.selectedIndex].value

}
else {
 alert("Please select an option.")
}
}